Sorbet Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 M
as on 04-12-2024
About Sorbet Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.10 M.
Vaijanath Awasare and Darshana Awasare serve as directors at the Company.
- CIN/LLPIN
U24232PN2011PTC138544
- Company No.
138544
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sorbet Pharmaceuticals Private Limited offer?
Sorbet Pharmaceuticals Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Dermatology Treatment Services.
Who are the key members and board of directors at Sorbet Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaijanath Awasare  | Director | 15-Feb-2011 | Current |
| Darshana Awasare | Director | 03-Dec-2018 | Current |
Financial Performance of Sorbet Pharmaceuticals.
Sorbet Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sorbet Pharmaceuticals?
In 2017, Sorbet Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pajas Pharmacia Private LimitedActive 6 years 6 monthsVaijanath Awasare and Darshana Awasare are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Jan 2020 | ₹0.60 M | Open |
Others Creation Date: 22 May 2014 | ₹0.50 M | Open |
How Many Employees Work at Sorbet Pharmaceuticals?
Unlock and access historical data on people associated with Sorbet Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sorbet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sorbet Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
